Mark Massaro
Stock Analyst at BTIG
(4.39)
# 1,250
Out of 5,044 analysts
1047
Total ratings
41.1%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Upgraded: Buy | $28 | $16.35 | +71.25% | 36 | Oct 6, 2026 | |
| PSNL Personalis | Downgraded: Hold | n/a | $16.00 | - | 39 | Oct 6, 2026 | |
| CDNA CareDx | Reiterated: Buy | $60 → $74 | $63.67 | +16.22% | 35 | Sep 24, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $25 → $34 | $26.49 | +28.35% | 44 | Sep 22, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | $5 | $13.00 | -61.54% | 28 | Sep 4, 2026 | |
| GH Guardant Health | Reiterated: Buy | $195 | $167.47 | +16.44% | 50 | Sep 1, 2026 | |
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.01 | - | 30 | Aug 24, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $4 → $2 | $0.5897 | +239.16% | 15 | Aug 21, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $70 → $80 | $70.93 | +12.79% | 12 | Aug 20, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $3.37 | - | 24 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $15.78 | +7.73% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.638 | +291.85% | 25 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.30 | +73.91% | 25 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 | $8.84 | -9.50% | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $33 | $29.70 | +11.11% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $320 | $400.71 | -20.14% | 80 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 → $130 | $98.09 | +32.53% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $7.41 | +21.46% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $8.42 | +6.89% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $67.33 | +33.67% | 37 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $34.42 | +27.83% | 35 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $74.81 | +113.88% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $518.00 | +54.44% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.44 | n/a | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $3.40 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0007 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $13.42 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $3.90 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $3.28 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $310 | $278.17 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $173 → $170 | $312.15 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $113 | $230.97 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.26 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $16.89 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $149 → $145 | $183.75 | n/a | 2 | May 7, 2015 |
NeoGenomics
Oct 6, 2026
Upgraded: Buy
Price Target: $28
Current: $16.35
Upside: +71.25%
Personalis
Oct 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $16.00
Upside: -
CareDx
Sep 24, 2026
Reiterated: Buy
Price Target: $60 → $74
Current: $63.67
Upside: +16.22%
Adaptive Biotechnologies
Sep 22, 2026
Reiterated: Buy
Price Target: $25 → $34
Current: $26.49
Upside: +28.35%
Ginkgo Bioworks Holdings
Sep 4, 2026
Reiterated: Sell
Price Target: $5
Current: $13.00
Upside: -61.54%
Guardant Health
Sep 1, 2026
Reiterated: Buy
Price Target: $195
Current: $167.47
Upside: +16.44%
MaxCyte
Aug 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.01
Upside: -
MDxHealth
Aug 21, 2026
Reiterated: Buy
Price Target: $4 → $2
Current: $0.5897
Upside: +239.16%
Tempus AI
Aug 20, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $70.93
Upside: +12.79%
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.37
Upside: -
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $15.78
Upside: +7.73%
Aug 17, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.638
Upside: +291.85%
Aug 14, 2026
Reiterated: Buy
Price Target: $4
Current: $2.30
Upside: +73.91%
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $8.84
Upside: -9.50%
Aug 7, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $29.70
Upside: +11.11%
Aug 7, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $400.71
Upside: -20.14%
Aug 6, 2026
Reiterated: Buy
Price Target: $142 → $130
Current: $98.09
Upside: +32.53%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $7.41
Upside: +21.46%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.42
Upside: +6.89%
Aug 4, 2026
Reiterated: Buy
Price Target: $90
Current: $67.33
Upside: +33.67%
Aug 3, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $34.42
Upside: +27.83%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $74.81
Upside: +113.88%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $518.00
Upside: +54.44%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.44
Upside: n/a
May 20, 2024
Reiterated: Buy
Price Target: $2
Current: $3.40
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Nov 17, 2019
Reiterated: Buy
Price Target: $70 → $75
Current: $13.42
Upside: n/a
Nov 10, 2019
Reiterated: Hold
Price Target: $7 → $8
Current: $3.90
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $35
Current: $3.28
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $300 → $310
Current: $278.17
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $173 → $170
Current: $312.15
Upside: n/a
Oct 22, 2019
Reiterated: Buy
Price Target: $112 → $113
Current: $230.97
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.26
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $16.89
Upside: n/a
May 7, 2015
Reiterated: Hold
Price Target: $149 → $145
Current: $183.75
Upside: n/a